DIMENSIONAL FUND ADVISORS LP - RHYTHM PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,223,036
+29.6%
96,948
-6.7%
0.00%0.0%
Q2 2023$1,714,739
-22.8%
103,958
-16.5%
0.00%0.0%
Q1 2023$2,221,004
+55564.3%
124,509
-9.1%
0.00%0.0%
Q4 2022$3,990
-99.9%
136,991
-38.6%
0.00%
-50.0%
Q3 2022$5,466,000
+420.6%
223,131
-11.9%
0.00%
Q2 2022$1,050,000
-52.9%
253,241
+30.7%
0.00%
-100.0%
Q1 2022$2,231,000
+40.7%
193,709
+21.9%
0.00%
Q4 2021$1,586,000
-32.7%
158,869
-12.0%
0.00%
-100.0%
Q3 2021$2,357,000
-58.5%
180,445
-37.8%
0.00%
-50.0%
Q2 2021$5,684,000
-13.5%
290,270
-5.9%
0.00%0.0%
Q1 2021$6,574,000
-34.9%
308,573
-9.2%
0.00%
-50.0%
Q4 2020$10,098,000
+39.2%
339,657
+1.4%
0.00%
+33.3%
Q3 2020$7,256,000
+0.9%
334,814
+3.8%
0.00%0.0%
Q2 2020$7,194,000
+76.1%
322,635
+20.1%
0.00%
+50.0%
Q1 2020$4,086,000
-34.7%
268,531
-1.5%
0.00%0.0%
Q4 2019$6,258,000
+11.7%
272,546
+5.0%
0.00%0.0%
Q3 2019$5,603,000
+19.0%
259,514
+21.3%
0.00%0.0%
Q2 2019$4,708,000
+75.8%
214,017
+119.3%
0.00%
+100.0%
Q1 2019$2,678,000
+85.1%
97,611
+81.4%
0.00%0.0%
Q4 2018$1,447,00053,8240.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Opaleye Management Inc. 810,000$19,845,0008.20%
NEA Management Company, LLC 4,912,306$108,316,0005.41%
Frazier Life Sciences Management, L.P. 1,894,000$46,403,0003.57%
RA Capital Management 5,471,067$134,041,0002.86%
Samsara BioCapital, LLC 345,293$8,460,0001.97%
Altium Capital Management LP 170,000$4,165,0001.53%
Parkman Healthcare Partners LLC 187,989$4,606,0001.31%
Rock Springs Capital Management LP 1,760,865$43,141,0001.11%
EAM Investors, LLC 198,699$4,868,0001.06%
Prosight Management, LP 80,000$1,960,0001.05%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders